Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
GW24-e3040 The influence of rosiglitazone on the expression of TNF-a and CX43 in dogs of chronic myocardial ischaemia
View through CrossRef
Objectives
To observe the effects of rosiglitazone on myocardial fibrosis of chronic myocardial ischaemia in dogs.
Methods
30 male healthy dogs of clean grade, were randomly divided into control group with 10 dogs, chronic myocardial ischaemia group with 10 dogs and rosiglitazone intervention group was 10 dogs. Dogs in Chronic myocardial ischaemia group and the rosiglitazone intervention group were injected 4% isoproterenol 50 mg everyday while dogs in control group were injected equal normal saline for eight weeks. Three weeks later, dogs in rosiglitazone intervention group were lavaged with rosiglitazone (3 mg/kg) everyday for four weeks. Dogs in the other groups were lavaged with equal normal saline. Immunohistochemical staining was used to detect the expressions of TNF-a and CX43 in myocardium of dogs and HE staining was used to detect the extent of myocardial fibrosis in dogs.
Results
The extent of myocardial fibrosis and the expressions of TNF-a and CX43 were significantly higher in dogs of Chronic myocardial ischaemia group and rosiglitazone intervention group than in the control group and rosiglitazone intervention group were significantly lower than chronic myocardial ischaemia group.
Conclusions
Rosiglitazone can reduce myocardial fibrosis of chronic myocardial ischaemia dogs and improve myocardial remodelling.
Title: GW24-e3040 The influence of rosiglitazone on the expression of TNF-a and CX43 in dogs of chronic myocardial ischaemia
Description:
Objectives
To observe the effects of rosiglitazone on myocardial fibrosis of chronic myocardial ischaemia in dogs.
Methods
30 male healthy dogs of clean grade, were randomly divided into control group with 10 dogs, chronic myocardial ischaemia group with 10 dogs and rosiglitazone intervention group was 10 dogs.
Dogs in Chronic myocardial ischaemia group and the rosiglitazone intervention group were injected 4% isoproterenol 50 mg everyday while dogs in control group were injected equal normal saline for eight weeks.
Three weeks later, dogs in rosiglitazone intervention group were lavaged with rosiglitazone (3 mg/kg) everyday for four weeks.
Dogs in the other groups were lavaged with equal normal saline.
Immunohistochemical staining was used to detect the expressions of TNF-a and CX43 in myocardium of dogs and HE staining was used to detect the extent of myocardial fibrosis in dogs.
Results
The extent of myocardial fibrosis and the expressions of TNF-a and CX43 were significantly higher in dogs of Chronic myocardial ischaemia group and rosiglitazone intervention group than in the control group and rosiglitazone intervention group were significantly lower than chronic myocardial ischaemia group.
Conclusions
Rosiglitazone can reduce myocardial fibrosis of chronic myocardial ischaemia dogs and improve myocardial remodelling.
Related Results
Abstract 15068: Connexin43 Concerns Arrhythmias Through Changes in Mitochondrial Ca
2+
and ROS
Abstract 15068: Connexin43 Concerns Arrhythmias Through Changes in Mitochondrial Ca
2+
and ROS
Introduction:
Connexin43 (Cx43) is a connexin that forms gap junctions in hearts and exists as hemichannels in the inner mitochondrial membrane (mCx43). It is still unk...
AKAP95 transports Cx43 into nucleus, regulating G1/S transition of A549 cells.
AKAP95 transports Cx43 into nucleus, regulating G1/S transition of A549 cells.
Abstract
Purpose: Cx43 (connexin 43) has been found to inhibit cell cycle of tumor cells. No nuclear localization sequence of Cx43 was found but the protein has been found ...
Effect of WenXin KeLi on Improvement of Arrhythmia after Myocardial Infarction by Intervening PI3K-AKT-mTOR Autophagy Pathway
Effect of WenXin KeLi on Improvement of Arrhythmia after Myocardial Infarction by Intervening PI3K-AKT-mTOR Autophagy Pathway
Background. Myocardial infarction (MI) is an acute and serious cardiovascular disease. Arrhythmia after MI can lead to sudden cardiac death, which seriously affects the survival ou...
e0046 Rosiglitazone attenuates myocardial remodelling in spontaneously hypertensive rats
e0046 Rosiglitazone attenuates myocardial remodelling in spontaneously hypertensive rats
Background
Rosiglitazone, an important Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist, improves left ventricular hypertrophy in diet-induced hyperc...
Application of TEM: Dynamic changes of AKAP95-Cx43 complex during G1 phase of lung cancer cells
Application of TEM: Dynamic changes of AKAP95-Cx43 complex during G1 phase of lung cancer cells
Abstract
BackgroundAKAP95(A-kinase anchoring protein) and Cx43 (connexin 43) express abnormally in lung cancer cells. As potential tumor therapeutic targets, specific proce...
The Specific Connexin 43–Inhibiting Peptide Gap26 Improved Alveolar Development of Neonatal Rats With Hyperoxia Exposure
The Specific Connexin 43–Inhibiting Peptide Gap26 Improved Alveolar Development of Neonatal Rats With Hyperoxia Exposure
Bronchopulmonary dysplasia (BPD) is a common devastating pulmonary complication in preterm infants. Alveolar maldevelopment is the crucial pathological change of BPD highly associa...
Tumor Necrosis Factor-α-Induced Anterior Pituitary Folliculostellate TtT/GF Cell Uncoupling Is Mediated by Connexin 43 Dephosphorylation
Tumor Necrosis Factor-α-Induced Anterior Pituitary Folliculostellate TtT/GF Cell Uncoupling Is Mediated by Connexin 43 Dephosphorylation
The anterior pituitary folliculostellate (FS) cells are key elements of the paracrine control of the pituitary function. These cells are the source and the target of growth factors...
Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway
Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway
Abstract
Hyperglycemia-induced renal epithelial-to-mesenchymal transition (EMT) is a key pathological factor in diabetic renal tubulointerstitial fibrosis (RIF). Our...